Serialisation represents a huge challenge for the industry. From the costly and complex implementation process, to the enormous task of data management, many within the pharmaceutical industry have found serialisation to be a daunting prospect.

There are undoubtedly additional benefits to be gained as a result of track and trace implementation. For example, data visibility and sharing capabilities across the pharmaceutical supply chain will drastically increase

However, the benefits of track and trace solutions go far beyond compliance and companies who are ready ahead of regulatory deadlines will be the ones to reap the rewards that increased visibility can offer the supply chain.  

In this roundtable with Manufacturing Chemist, Staffan Widengren, Director Corporate Projects at Recipharm discusses these benefits and looks at what track and trace regulations could mean for the future of the pharmaceutical industry.

Read part two of the roundtable here: The Manufacturing Chemist – anti-counterfeiting roundtable part two